Klotho and the pathogenesis of cardiovascular disease
Klotho and the pathogenesis of cardiovascular disease
批准号:
8856643
负责人:
RICHARD D SEMBA
金额:
$35.85万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-07-01 至 2017-05-31
关键词:
AddressAdultAgeAgingAnimal Disease ModelsAnimal ModelAnimalsAtherosclerosisAtrophic condition of skinAwardBindingBlood CirculationBone DensityCaliforniaCardiacCardiovascular DiseasesCardiovascular systemCell Adhesion MoleculesCessation of lifeCohort StudiesCommunitiesCongestive Heart FailureCoronary ArteriosclerosisCoronary heart diseaseCountryDataDiseaseElderlyEndotheliumEnzyme-Linked Immunosorbent AssayEventGene DeliveryGenesGoalsGreekHealthHormonesHumanHypertensionImpaired cognitionIndividualInflammationIntegral Membrane ProteinInterventionInvestigationItalyKidneyKnowledgeLifeLongevityLongitudinal StudiesMaintenanceMarylandMeasuresMedialMediatingMedicalMembraneMorbidity - disease rateMusMutant Strains MiceMyocardial InfarctionMythologyNamesNitric OxideNorth CarolinaParticipantPathogenesisPathway interactionsPennsylvaniaPeripheral arterial diseasePhenotypePlasmaPopulationProductionPublic HealthRegulationRiskRisk FactorsRoleSerumSingle Nucleotide PolymorphismStrokeStudy of serumTherapeuticTherapeutic InterventionThickTransgenic MiceTransient Ischemic AttackUnited States National Institutes of HealthVascular PermeabilitiesVisitWild Type Mouseaging geneanti agingbasecardiovascular healthcardiovascular risk factorendothelial dysfunctionfollow-upgenome wide association studyhuman diseasein vivoinnovationinsightinterestintimal medial thickeningmortalitynew therapeutic targetnoveloverexpressionpopulation basedreceptorsarcopenia
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Cardiovascular disease is the leading cause of morbidity and mortality in western countries. Despite substantial medical progress in identifying modifiable cardiovascular risk factors, a significant proportion of individuals with cardiovascular
disease have no known risk factors. Klotho is a recently discovered hormone found to protect against endothelial dysfunction, atherosclerosis, and cardiovascular disease in mice, as well as to extend lifespan. The klotho gene encodes a single-pass transmembrane protein that exists as a circulating hormone and as a membrane-bound co-receptor. Klotho regulates nitric oxide production, vascular permeability, suppression of inflammation, and expression of adhesion molecules by the endothelium. In the absence of klotho hormone, endothelial dysfunction and hypertension occur in animal models, which are reversible or preventable with in vivo delivery of the klotho gene. Until recently, there was no way to measure levels of klotho in the circulation. We are the first to measure klotho levels in a large number of people. Our preliminary data support the premise that klotho is protective against cardiovascular disease in humans. Based upon knowledge of klotho and our preliminary data, we hypothesize that older people with low circulating klotho levels are at increased risk of cardiovascular events and mortality, and that klotho levels are associated with impaired brachial flow-mediated dilation. We propose to characterize the relationship of serum klotho with prevalent cardiovascular disease (myocardial infarction, angina, stroke, congestive heart failure, peripheral artery disease, transient ischemic
attack), carotid intima-media thickness, brachial flow-mediated dilation, cardiovascular events and mortality in the Cardiovascular Health Study, an NIH-supported, population-based, longitudinal study of coronary heart disease and stroke in US adults. We will also conduct a genome-wide association study of serum klotho levels. This project will determine whether serum klotho is a major risk factor for cardiovascular disease and will provide novel insight into the role of klotho in human health. The project should provide the rationale and evidence for klotho as a potential novel therapeutic target for intervention in cardiovascular disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Lysophosphatidylcholines and Cognition (L-COG) Study
-
批准号:10242168
-
项目类别:
-
资助金额:$12.28万
-
财政年份:2020
-
负责人:RICHARD D SEMBA
-
依托单位:
Lysophosphatidylcholines and Cognition (L-COG) Study
-
批准号:10040903
-
项目类别:
-
资助金额:$12.28万
-
财政年份:2020
-
负责人:RICHARD D SEMBA
-
依托单位:
Systemic rejuvenating factors and human aging phenotypes.
-
批准号:10421273
-
项目类别:
-
资助金额:$35.21万
-
财政年份:2018
-
负责人:RICHARD D SEMBA
-
依托单位:
Systemic rejuvenating factors and human aging phenotypes.
-
批准号:10152484
-
项目类别:
-
资助金额:$35.21万
-
财政年份:2018
-
负责人:RICHARD D SEMBA
-
依托单位:
Relationship of candidate circulating proteoforms with aging phenotypes.
-
批准号:9248089
-
项目类别:
-
资助金额:$21.06万
-
财政年份:2016
-
负责人:RICHARD D SEMBA
-
依托单位:
Systemic complement and age-related macular degeneration.
-
批准号:8913193
-
项目类别:
-
资助金额:$55.93万
-
财政年份:2014
-
负责人:RICHARD D SEMBA
-
依托单位:
Systemic complement and age-related macular degeneration.
-
批准号:9131741
-
项目类别:
-
资助金额:$47.22万
-
财政年份:2014
-
负责人:RICHARD D SEMBA
-
依托单位:
Klotho and the pathogenesis of cardiovascular disease
-
批准号:8371479
-
项目类别:
-
资助金额:$42.0万
-
财政年份:2012
-
负责人:RICHARD D SEMBA
-
依托单位:
Klotho and the pathogenesis of cardiovascular disease
-
批准号:8499415
-
项目类别:
-
资助金额:$34.65万
-
财政年份:2012
-
负责人:RICHARD D SEMBA
-
依托单位:
Klotho and cardiovascular disease in the Honolulu Heart Program
-
批准号:8262248
-
项目类别:
-
资助金额:$12.15万
-
财政年份:2012
-
负责人:RICHARD D SEMBA
-
依托单位:
Klotho and the pathogenesis of cardiovascular disease
-
批准号:8675929
-
项目类别:
-
资助金额:$35.67万
-
财政年份:2012
-
负责人:RICHARD D SEMBA
-
依托单位:
Klotho and cardiovascular disease in the Honolulu Heart Program
-
批准号:8473274
-
项目类别:
-
资助金额:$11.57万
-
财政年份:2012
-
负责人:RICHARD D SEMBA
-
依托单位:
Advanced glycation end products and cardiovascular disease
-
批准号:7726388
-
项目类别:
-
资助金额:$41.0万
-
财政年份:2009
-
负责人:RICHARD D SEMBA
-
依托单位:
Advanced glycation end products and cardiovascular disease
-
批准号:8100250
-
项目类别:
-
资助金额:$41.0万
-
财政年份:2009
-
负责人:RICHARD D SEMBA
-
依托单位:
Advanced glycation end products and cardiovascular disease
-
批准号:7895825
-
项目类别:
-
资助金额:$41.0万
-
财政年份:2009
-
负责人:RICHARD D SEMBA
-
依托单位:
Hepcidin and the pathogenesis of anemia in older adults.
-
批准号:7172734
-
项目类别:
-
资助金额:$31.92万
-
财政年份:2007
-
负责人:RICHARD D SEMBA
-
依托单位:
Hepcidin and the pathogenesis of anemia in older adults.
-
批准号:7586171
-
项目类别:
-
资助金额:$29.75万
-
财政年份:2007
-
负责人:RICHARD D SEMBA
-
依托单位:
Hepcidin and the pathogenesis of anemia in older adults.
-
批准号:7797478
-
项目类别:
-
资助金额:$29.45万
-
财政年份:2007
-
负责人:RICHARD D SEMBA
-
依托单位:
Hepcidin and the pathogenesis of anemia in older adults.
-
批准号:7363713
-
项目类别:
-
资助金额:$29.75万
-
财政年份:2007
-
负责人:RICHARD D SEMBA
-
依托单位:
BEEF CONSUMPTION TO REDUCE IRON DEFICIENCY AND COGNITIVE FUNCTION IN WOMEN
-
批准号:7378909
-
项目类别:
-
资助金额:$0.22万
-
财政年份:2005
-
负责人:RICHARD D SEMBA
-
依托单位:
海外基金